Latest 10-Q quarterly reports

Tomi Environmental Solutions announced a significant revenue increase in Q2 2026, driven by product sales, while also detailing progress on its merger with Carbonium Core, Inc. and addressing ongoing financial challenges.

PMGC Holdings Inc. files its Q2 2026 Form 10-Q, detailing significant revenue growth from recent acquisitions but also substantial net losses and ongoing going concern uncertainties.

WinVest Acquisition Corp. reports a substantial doubt about its going concern status in its Q2 2026 10-Q filing, citing liquidity issues and an impending liquidation deadline.

Skye Bioscience terminates nimacimab R&D, pauses clinical trials, and focuses on a proposed acquisition of Redx Pharma, while facing ongoing financial and listing challenges.

Techlott Inc. reported a net loss of $1.87 million for Q2 2026, with significant R&D and amortization expenses, while facing substantial doubt about its ability to continue as a going concern.

Canton Strategic Holdings, Inc. reported its second quarter 2026 financial results, highlighting new revenue from network validation and locking-as-a-service, but also significant unrealized losses on its digital asset holdings.

Genprex, Inc. reports on its Q2 2026 progress, highlighting advancements in its oncology and diabetes gene therapy programs, while addressing ongoing liquidity concerns and Nasdaq compliance.

Upland Software's Q2 2026 results show an 8% revenue decline, a $35.2 million goodwill impairment, and ongoing challenges with Nasdaq listing requirements.

Silexion Therapeutics Corp. filed its Q2 2026 Form 10-Q, detailing increased R&D expenses for its SIL204 trial, ongoing financing efforts, and substantial doubt regarding its ability to continue as a going concern.

Community Bancorp. reported a 15.5% increase in net income for Q2 2026, driven by higher interest income and improved net interest margins, despite a rise in credit loss expenses.

Kartoon Studios, Inc. announced its Q2 2026 financial results, showcasing a significant net income driven by a $39.2 million legal settlement, though operational revenues declined.

Algorhythm Holdings, Inc. (RIME) filed its Q2 2026 10-Q, detailing revenue growth driven by its SemiCab business, but also highlighting substantial net losses, a precarious going concern status, and ongoing efforts to secure financing.

Volato Group's Q2 2026 Form 10-Q reveals a substantial 96% revenue decrease driven by the cessation of aircraft sales, while subscription revenue shows growth.

ClearSign Technologies Corporation's Q2 2026 Form 10-Q filing reveals a substantial increase in revenue, but also a significant rise in cost of goods sold leading to a gross loss for the six-month period.

Wintergreen Acquisition Corp. reports on its financial status and progress towards its business combination with KIKA Technology Inc. for the quarter ended June 30, 2026.

BHAV Acquisition Corp reports net income for Q2 2026, driven by interest income, while acknowledging substantial doubt about its ability to continue as a going concern.

Strategic Acquisitions, Inc. filed its Q2 2026 Form 10-Q, reporting no revenue, continued net losses, and substantial doubt about its ability to continue as a going concern, despite recent financing.

Nomad Power Solutions, Inc. (formerly Lixte Biotechnology Holdings, Inc.) reported its Q2 2026 results, highlighting a strategic shift into AI energy infrastructure and the completion of its merger with NOMAD Transportable Power Systems, Inc.

Non-Invasive Monitoring Systems, Inc. (NIMS) filed its Q2 2026 10-Q, reporting increased operating losses and continued going concern doubts, while extending its merger deadline with Gravitics, Inc. to September 30, 2026.

Dragonfly Energy Holdings Corp. reported a decrease in net sales for the second quarter of 2026 compared to the prior year, alongside continued net losses, though gross profit margin improved due to tariff refunds.

Professional Diversity Network, Inc. reported a net loss of $3.57 million for the six months ended June 30, 2026, with ongoing concerns about its ability to continue as a going concern.

Agape ATP Corporation reported a sharp decline in revenue and continued net losses for the second quarter of 2026, raising concerns about its financial stability.

Aptevo Therapeutics Inc. reported continued net losses and a substantial accumulated deficit, raising substantial doubt about its ability to continue as a going concern, despite recent financing efforts.

Our Bond Inc. reported a net loss of $4.77 million for Q2 2026, with total revenue decreasing by 6.77% year-over-year, while operating expenses surged by 23.47%.

Leatt Corporation's Q2 2026 Form 10-Q filing reveals a 14% year-over-year revenue increase driven by strong performance in body armor and helmets, alongside improved gross margins.

Allarity Therapeutics, Inc. filed its Q2 2026 10-Q, revealing continued net losses and a substantial accumulated deficit, while highlighting efforts to manage expenses and secure future funding.

Clene Inc. reported significant net losses and cash outflows in its Q2 2026 10-Q filing, raising substantial doubt about its ability to continue as a going concern.

GT Biopharma's Q2 2026 report highlights significant operating losses and cash burn, raising substantial doubt about its ability to continue as a going concern, despite progress in its clinical pipeline.

Zapata Quantum, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing ongoing operational losses, a significant cash balance post-financing, and efforts to restructure debt and operations.

1847 Holdings LLC's Q2 2026 Form 10-Q reveals significant revenue declines and substantial net losses, with management expressing substantial doubt about the company's ability to continue as a going concern.